covid 19 News and Research

RSS

Novel compounds show promise in fighting COVID-19

New research from The Wistar Institute's Salvino lab - led by professor Joseph Salvino, Ph.D. - has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, according to preclinical testing, effectively inhibits COVID-19 and synergizes with existing anti-COVID therapies.

8 Oct 2024

Maintaining healthy weight may support brain vascular health in aging population

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 18 on September 18, 2024, entitled, "Determinants of cerebral blood flow and arterial transit time in healthy older adults."

8 Oct 2024

New EU project aims to enhance pandemic preparedness

Covid-19 came like a bolt from the blue. The health, social and economic repercussions of this pandemic event have been considerable and, four years on, we are still suffering from them.

8 Oct 2024

Modified bloodroot compound shows promise against multidrug-resistant tuberculosis

A modified compound taken from bloodroot, a wildflower native to North America, effectively fights multidrug-resistant tuberculosis (TB) bacteria in the test tube, according to a new study.

8 Oct 2024

New insights into family adaptation in Singapore during the COVID-19 pandemic

A new study by the National University of Singapore Yong Loo Lin School of Medicine (NUS Medicine) analyzing the resilience of Singaporean families during the COVID-19 pandemic has uncovered significant findings that highlight how most families with young children successfully adapted to the challenges brought by the global crisis.

8 Oct 2024

Brainstem inflammation may explain long Covid symptoms

Damage to the brainstem – the brain's 'control center' – is behind long-lasting physical and psychiatric effects of severe Covid-19 infection, a study suggests.

8 Oct 2024

FAU researchers highlight new vaccination barriers

Vaccines to prevent common and serious infectious diseases have had a greater impact on improving human health than any other medical advance of the 20th century, surpassing even sanitation and potable water. From the global eradication of smallpox in 1980 to the unprecedented development of effective and safe mRNA vaccines for COVID-19, vaccinations have played crucial roles in preventing millions of premature deaths and hospitalizations in adults and children.

8 Oct 2024

British adults in midlife show better cardiovascular health than American counterparts

Rates of obesity, high blood pressure and high cholesterol are lower among British adults in their 30s and 40s compared to their counterparts in the US, according to a new study led by UCL researchers.

7 Oct 2024

One-dose HPV vaccination could eliminate cervical cancer in Canada

Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modeling in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.240787.

7 Oct 2024

Antigenic mapping sheds light on SARS-CoV-2 immunity differences

A person's immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure - and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.

7 Oct 2024

Young Australians face stagnating life expectancy trends

Australians under 50 are experiencing stagnating life expectancy while older cohorts, especially men, are living longer, according to new research from The Australian National University (ANU).

7 Oct 2024

COVID-19 increases chronic fatigue risk

Study reveals that COVID-19 significantly increases the risk of chronic fatigue syndrome, with specific populations, such as older adults, Asians, and non-hospitalized patients, at higher risk.

7 Oct 2024

Thousands could have been saved during the pandemic with expanded use of convalescent plasma

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission.

4 Oct 2024

Trump leads, and his party follows, on vaccine skepticism

More than four years ago, former President Donald Trump’s administration accelerated the development and rollout of the covid-19 vaccine.

4 Oct 2024

Here’s why getting a covid shot during pregnancy is important

Nearly 90% of babies who had to be hospitalized with covid-19 had mothers who didn't get the vaccine while they were pregnant, according to new data released by the Centers for Disease Control and Prevention.

4 Oct 2024

Stroke remains a leading cause of death globally, with increased risk linked to lifestyle factors

The Lancet Neurology study provides updated estimates on stroke burden and risks, emphasizing the need for targeted interventions in high-risk regions.

4 Oct 2024

How physical activity and diet impact sleep in adolescents

Researchers review the impact of physical activity and diet on the duration and quality of sleep among adolescents.

4 Oct 2024

Lithium aspartate fails to improve long COVID symptoms, but higher doses may hold promise

Lithium aspartate at 10-15 mg/d is ineffective for treating cognitive dysfunction and fatigue in long COVID, but higher doses may offer potential benefits based on a small follow-up study.

3 Oct 2024

Mild COVID-19 disrupts brain connectivity and reduces memory function in adolescents and young adults

Study reveals localized brain changes in adolescents and young adults post-COVID, including reduced hippocampal volume and disrupted connectivity, correlating with impaired working memory. These findings highlight the importance of understanding long-term cognitive effects of mild COVID-19.

3 Oct 2024

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government's Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.

3 Oct 2024

Previous
1
...
82
83
84
85
86
87
88
...
1308
Next

covid 19 News and Research

Novel compounds show promise in fighting COVID-19

Maintaining healthy weight may support brain vascular health in aging population

New EU project aims to enhance pandemic preparedness

Modified bloodroot compound shows promise against multidrug-resistant tuberculosis

New insights into family adaptation in Singapore during the COVID-19 pandemic

Brainstem inflammation may explain long Covid symptoms

FAU researchers highlight new vaccination barriers

British adults in midlife show better cardiovascular health than American counterparts

One-dose HPV vaccination could eliminate cervical cancer in Canada

Antigenic mapping sheds light on SARS-CoV-2 immunity differences

Young Australians face stagnating life expectancy trends

COVID-19 increases chronic fatigue risk

Thousands could have been saved during the pandemic with expanded use of convalescent plasma

Trump leads, and his party follows, on vaccine skepticism

Here’s why getting a covid shot during pregnancy is important

Stroke remains a leading cause of death globally, with increased risk linked to lifestyle factors

How physical activity and diet impact sleep in adolescents

Lithium aspartate fails to improve long COVID symptoms, but higher doses may hold promise

Mild COVID-19 disrupts brain connectivity and reduces memory function in adolescents and young adults

Houston Methodist researchers join national consortium to develop herpesvirus vaccine

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News